foto
LATEST NEWS

 OctoPlus announces 2010 first half-year results



WEBCAST HALF-YEAR RESULTS

Click here to access the webcast of 6 August 2010



OCTOPLUS OPENED NYSE EURONEXT

In celebration of OctoPlus' 15 year anniversday, CEO Simon Sturge and CFO Susan Swarte opened the financial markets in Amsterdam on Tuesday 27 July



OCTOPLUS ANNUAL REPORT 2009
VIEW OUR WEB SEMINARS
OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

COMPANY PROFILE

Pharmaceutical Innovators
OctoPlus is a drug delivery and drug development company that is globally renowned for its expertise and professionalism. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world.

Our business activities include pharmaceutical development services, drug delivery technologies and product development.

Pharmaceutical innovation at OctoPlus is achieved to the fullest, because:

Partner with OctoPlus
OctoPlus is dedicated to the pharmaceutical innovation of drug compounds, both by using proprietary and non-proprietary technologies and knowledge. We are flexible in constructing partnerships and co-development agreements, and are open to take on some of the risk and cost for the development of promising compounds. Please feel free to contact us and discuss your needs.

For more information on OctoPlus, please visit our Corporate Information page .